pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

701 catalysts · 3,369 8k filing · 1,458 grant · 1,000 device adverse event · 701 approval · 582 earnings · 540 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 20 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×from 2026-02-17×clear all
type
  • 8k filing3,369
  • grant1,458
  • device adverse event1,000
  • approval701
  • earnings582
  • device 510k540
device pma
346
  • phase 2 completion172
  • recall157
  • drug shortage133
  • therapy area

    no tagged catalysts yet

    Week of Feb 16, 2026

    50
    ›Feb 17, 2026approval182d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoIDELALISIB — FDA approvalIDELALISIB

    Sponsor: NATCO. Form: TABLET. Route: ORAL

    full page →IDELALISIB →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

    Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

    full page →SODIUM PHENYLBUTYRATE →fda approvals ↗
    ›Feb 17, 2026approval182d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoCOLCHICINE — FDA approvalCOLCHICINE

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →COLCHICINE →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval182d agoMEDICAL AIR, USP — FDA approval

    Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval182d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval182d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Feb 17, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval182d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval182d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval181d agoARBLI (LOSARTAN POTASSIUM) — FDA approvalLOSARTAN POTASSIUM

    Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL

    full page →LOSARTAN POTASSIUM →fda approvals ↗
    ›Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

    Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

    Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 18, 2026approval181d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

    Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →aripiprazole LA →fda approvals ↗
    ›Feb 18, 2026approval181d agoEBANGA (ANSUVIMAB-ZYKL) — FDA approvalansuvimab

    Sponsor: RIDGEBACK BIOTHERAPEUTICS. Form: POWDER. Route: IV (INFUSION)

    full page →ansuvimab →fda approvals ↗
    ›Feb 18, 2026approval181d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: IPCA LABS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 19, 2026approval180d agoELREXFIO (ELRANATAMAB) — FDA approvalelranatamab

    Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION

    full page →elranatamab →fda approvals ↗
    ›Feb 19, 2026approval180d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 19, 2026approval180d agoBRIVARACETAM — FDA approvalBRIVARACETAM

    Sponsor: MSN. Form: SOLUTION. Route: ORAL

    full page →BRIVARACETAM →fda approvals ↗
    ›Feb 19, 2026approval180d agoPOTELIGEO (MOGAMULIZUMAB-KPKC) — FDA approvalmogamulizumab

    Sponsor: KYOWA KIRIN. Form: INJECTABLE. Route: INJECTION

    full page →mogamulizumab →fda approvals ↗
    ›Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 19, 2026approval180d agoCALQUENCE (ACALABRUTINIB MALEATE) — FDA approvalCALQUENCE

    Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

    full page →CALQUENCE →fda approvals ↗
    ›Feb 19, 2026approval180d agoCALQUENCE (ACALABRUTINIB) — FDA approvalCALQUENCE

    Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

    full page →CALQUENCE →fda approvals ↗
    ›Feb 19, 2026approval180d agoVENCLEXTA (VENETOCLAX) — FDA approvalvenetoclax

    Sponsor: ABBVIE. Form: TABLET. Route: ORAL

    full page →venetoclax →fda approvals ↗
    ›Feb 20, 2026approval179d agoFAVLYXA (FLUOROURACIL) — FDA approvalEfudex

    Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS

    full page →Efudex →fda approvals ↗
    ← prev
    page 1 of 15
    next →
    $AZN156.58+0.08%
    $ABBV250.21+0.30%
    $PYPD4.8500+2.33%
    $PFE26.95+0.62%
    $AZN156.58+0.08%
    $SCNX0.3314-4.08%